- Sanders DB, Howard JF, Jr. Disorders of neuromuscular transmission. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in Clinical Practice. New York: Butterworths Publishers, 2000: 2167-2185.
- Sanders DB, Andrews PI, Howard JF, Jr., Massey JM. Seronegative myasthenia gravis. Neurology 1997; 48 (Suppl 5):S40-S51.
- Mossman S, Vincent A, Newsom-Davis J. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet 1986; 1:116-119.
- Sanders DB, el-Salem K, Massey JM, McConville J, Vincent A. Clinical aspects of MuSK Antibody Positive Seronegative Myasthenia Gravis (SNMG). Neurology 2003; 60:1978-1980.
- Scuderi F, Marino M, Colonna L, Mannella F, Evoli A, Provenzano C et al. Anti-P110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement. Lab Invest 2002; 82:1139-1146.
- Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nature Medicine 2001; 7:365-368.
